Looking for a Medisafe alternative?
In January 2026, Medisafe put its core features behind a subscription. If you just want medication reminders that fire on time — without ads, a mandatory account, or a paywall on the basics — here's an honest look at where TakeMyPills fits.
In January 2026, Medisafe moved to a required subscription: $4.99 a month or $39.99 a year. The free version is now limited to 2 medications, and Medfriend alerts — the feature that warns a relative when a dose is missed — became paid. The reaction has been visible: the app's Google Play rating has fallen to around 2.9, and recent reviews keep repeating the same two complaints — the new paywall, and reminders arriving late, sometimes by several hours.
There is nothing wrong with paid software — we sell apps too. But the people leaving Medisafe mostly describe the same wish list: a simple app, no mandatory account, free or honestly priced, notifications that actually arrive on time, and health data that stays private.
TakeMyPills, our medication reminder, was built around exactly those points. Reminders are sent from our server rather than scheduled on the phone, so they arrive even if the app is closed or the phone was restarted. It is designed for households: profiles for yourself, your children, or ageing parents, and a family sync that lets a caregiver see that a dose was taken — without exposing what the treatment is. No ads, no required account, and the data stays within the family.
Medisafe vs TakeMyPills
| Feature | TakeMyPills | Medisafe |
|---|---|---|
| Price | Free for the essentials | $4.99/month or $39.99/year (required since January 2026) |
| Medications on the free plan | The essentials free, multi-profile included | Limited to 2 |
| Family / caregiver alerts | Included — family sync shows a dose was taken, not the treatment details | Medfriend alerts are now a paid feature |
| Reminder reliability | Sent server-side — they fire even if the app is closed or the phone was rebooted | Recurring user reports of reminders arriving late, sometimes by hours |
| Account required | No — an optional family code is enough | Yes |
| Ads | None — no ads, no ad trackers | — |
Built for caregivers
TakeMyPills started from a caregiver's problem: helping several people take the right thing at the right time, without turning anyone's phone into a surveillance device.
- ✓Multiple profiles in one app — yourself, your kids, your ageing parents, each with their own schedule and history
- ✓Family sync: see at a glance that a dose was taken, without seeing the details of someone's treatment
- ✓Notifications never spell out a medication name, so a lock screen reveals nothing
- ✓No account to create — a shared family code is enough, and the data stays within the family
Frequently Asked Questions
+Is Medisafe still free?
Partly. A free version still exists, but since January 2026 it is limited to 2 medications, and features like Medfriend alerts require the subscription — $4.99 a month or $39.99 a year. For anyone managing more than two medications, Medisafe is effectively a paid app now.
+How do I switch from Medisafe to TakeMyPills?
There is no automatic import — you re-create your schedule by hand, which takes a few minutes for most people. TakeMyPills covers the shapes real prescriptions take: fixed daily times, every X hours, specific weekdays only, time-limited courses ("10 days, then stop") or ongoing treatments.
+Will TakeMyPills force a subscription later, like Medisafe did?
The essentials are free, and there are no ads. We are a small independent studio and we deliberately don't publish a full pricing table while the app is pre-launch — but the core of the app, reliable reminders for your family, is free to use.
+When can I download TakeMyPills?
Very soon. The iOS app is in Apple's review queue and the Android app is in closed testing — that's why there is no download button on this page yet. In the meantime, you can find our other apps on the TrainRBoost homepage.
Reminders your family can rely on
TakeMyPills is in the last stretch before launch: iOS is in App Store review, Android is in closed testing.
Coming soon to iOS and Android.
Meanwhile, explore the TrainRBoost apps →